See All Slides - tctmd.com

Slides

Presentation TCT 2012

Complication Management During TAVI

Presenter: Ulrich Gerckens

October 24, 2012

Presentation TCT 2012

Face the Facts, AUC Are Here to Stay: 2012 Update on the Current Use and Future Directions of AUC

Presenter: Manesh Patel

October 24, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

Presentation TCT 2012

Sutureless Surgical Aortic Valve Replacement: Is There a Role in the TAVR Era?

Presenter: Vinod Thourani

October 24, 2012

Presentation TCT 2012

All Arterial Revascularization: Is It Really Worth the Effort?

Presenter: Stephanie Mick

October 24, 2012

Presentation TCT 2012

Getting Real: Practical Next Steps

Presenter: Peter Fitzgerald

October 24, 2012

Presentation TCT 2012

Pragmatic Pre- and Post-Market Global Harmonization: Lessons from Japan and the United States

Presenter: Kenneth Cavanaugh Jr

October 24, 2012

Presentation TCT 2012

Is There Any Benefit in Recanalizing Chronic Central Venous Occlusions?

Presenter: Mahmood Razavi

October 24, 2012

Presentation TCT 2012

Physiologic Rationale for Interventional Therapies in Hypertension

Presenter: C. Venkata S. Ram

October 24, 2012

Presentation TCT 2012

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Presenter: Samir Kapadia

October 24, 2012

Advertisement

Slides

Complication Management During TAVI

Face the Facts, AUC Are Here to Stay: 2012 Update on the Current Use and Future Directions of AUC

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Sutureless Surgical Aortic Valve Replacement: Is There a Role in the TAVR Era?

All Arterial Revascularization: Is It Really Worth the Effort?

Getting Real: Practical Next Steps

Pragmatic Pre- and Post-Market Global Harmonization: Lessons from Japan and the United States

Is There Any Benefit in Recanalizing Chronic Central Venous Occlusions?

Physiologic Rationale for Interventional Therapies in Hypertension

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content